Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

04. März 2020 07:00 ET | Quelle: Allergy Therapeutics

Allergy Therapeutics Interim Results for the six months ended 31 December 2019

Allergy Therapeutics plc(“Allergy Therapeutics”, “ATL” or the “Group”)Interim Results for the six months ended 31 December 2019 Record level of operating profit pre R&D supported by strong...
27. Juni 2019 10:47 ET | Quelle: Allergy Therapeutics

Allergy Therapeutics plc - Successful litigation settlement relating to PQ Grass Phase II Trial

Allergy Therapeutics plc(“Allergy Therapeutics”, “ATL” or the “Group”) Successful litigation settlement relating to PQ Grass Phase II Trial 27 June 2019 Allergy Therapeutics plc (AIM: AGY), the...
27. Juni 2019 10:26 ET | Quelle: Allergy Therapeutics

Allergy Therapeutics plc - Trading Update and Successful Litigation Settlement

Allergy Therapeutics plc(“Allergy Therapeutics” or the “Group”) Trading Update and Successful Litigation Settlement 2019 full year earnings expected to be ahead of market expectations 27 June...
12. Juli 2018 07:00 ET | Quelle: Allergy Therapeutics

Allergy Therapeutics PLC: Trading Update

Allergy Therapeutics plc(“Allergy Therapeutics” or the “Group”) Trading update Group’s market share continues to grow 12 July 2018 Allergy Therapeutics plc (AIM: AGY), the fully integrated...